司美替尼-话题@MedSci

#司美替尼#

5篇内容 | 736人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2194911, encodeId=42182194911c3, content=<a href='/topic/show?id=b24138e29a0' target=_blank style='color:#2F92EE;'>#司美替尼#</a> <a href='/topic/show?id=5deae44758a' target=_blank style='color:#2F92EE;'>#神经纤维瘤#</a>, objectTitle=CTM | 司美替尼在中国成人/儿童神经纤维瘤患者中的I期临床数据, objectType=article, longId=816509, objectId=6083816509af, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-is-working-at-the-hospital-PBHANEP.jpg, objectUrl=/article/show_article.do?id=6083816509af, replyNumber=0, likeNumber=10, createdTime=2024-03-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6083816509af, moduleTitle=CTM | 司美替尼在中国成人/儿童神经纤维瘤患者中的I期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6083816509af)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1568066, encodeId=a1721568066fb, content=<a href='/topic/show?id=b24138e29a0' target=_blank style='color:#2F92EE;'>#司美替尼#</a>, objectTitle=Oncotarget：司美替尼药物组合治疗葡萄膜黑色素瘤, objectType=article, longId=139275, objectId=a4201392e56f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4201392e56f, replyNumber=0, likeNumber=35, createdTime=2018-05-29, rootId=0, userName=lqvr, userId=417515318083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4201392e56f, moduleTitle=Oncotarget：司美替尼药物组合治疗葡萄膜黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4201392e56f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1568065, encodeId=9536156806534, content=<a href='/topic/show?id=b24138e29a0' target=_blank style='color:#2F92EE;'>#司美替尼#</a>, objectTitle=BMC Cancer：司美替尼联合达卡巴嗪用于转移性葡萄膜黑色素瘤的临床研究, objectType=article, longId=52070, objectId=9fac520e0b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fac520e0b0, replyNumber=0, likeNumber=0, createdTime=2015-06-16, rootId=0, userName=lqvr, userId=417515318083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fac520e0b0, moduleTitle=BMC Cancer：司美替尼联合达卡巴嗪用于转移性葡萄膜黑色素瘤的临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fac520e0b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1568064, encodeId=88251568064f4, content=<a href='/topic/show?id=b24138e29a0' target=_blank style='color:#2F92EE;'>#司美替尼#</a>, objectTitle=JAMA：司美替尼（selumetinib）对葡萄膜黑色素瘤的治疗优于化疗, objectType=article, longId=36881, objectId=92203688172, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92203688172, replyNumber=0, likeNumber=25, createdTime=2014-06-25, rootId=0, userName=lqvr, userId=417515318083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92203688172, moduleTitle=JAMA：司美替尼（selumetinib）对葡萄膜黑色素瘤的治疗优于化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92203688172)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1568063, encodeId=fa5115680638d, content=<a href='/topic/show?id=b24138e29a0' target=_blank style='color:#2F92EE;'>#司美替尼#</a>, objectTitle=阿斯利康开展司美替尼用于NSCLC的III期临床研究, objectType=article, longId=25791, objectId=ebe925e9168, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebe925e9168, replyNumber=0, likeNumber=32, createdTime=2013-10-26, rootId=0, userName=lqvr, userId=417515318083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebe925e9168, moduleTitle=阿斯利康开展司美替尼用于NSCLC的III期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebe925e9168)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1568062, encodeId=8b761568062e6, content=<a href='/topic/show?id=b24138e29a0' target=_blank style='color:#2F92EE;'>#司美替尼#</a>, objectTitle=Lancer Oncol：司美替尼对复发的卵巢低分化鳞癌有效, objectType=article, longId=14151, objectId=e38e1415110, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e38e1415110, replyNumber=0, likeNumber=32, createdTime=2013-01-09, rootId=0, userName=lqvr, userId=417515318083, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e38e1415110, moduleTitle=Lancer Oncol：司美替尼对复发的卵巢低分化鳞癌有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e38e1415110)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

司美替尼

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#司美替尼# #神经纤维瘤#

CTM | 司美替尼在中国成人/儿童神经纤维瘤患者中的I期临床数据

2024-03-23发表于上海

lqvr (审核中...)

前往app查看评论内容

#司美替尼#

Oncotarget：司美替尼药物组合治疗葡萄膜黑色素瘤

2018-05-29

lqvr (审核中...)

前往app查看评论内容

#司美替尼#

BMC Cancer：司美替尼联合达卡巴嗪用于转移性葡萄膜黑色素瘤的临床研究

2015-06-16

lqvr (审核中...)

前往app查看评论内容

#司美替尼#

JAMA：司美替尼（selumetinib）对葡萄膜黑色素瘤的治疗优于化疗

2014-06-25

lqvr (审核中...)

前往app查看评论内容

#司美替尼#

阿斯利康开展司美替尼用于NSCLC的III期临床研究

2013-10-26

lqvr (审核中...)

前往app查看评论内容

#司美替尼#

Lancer Oncol：司美替尼对复发的卵巢低分化鳞癌有效

2013-01-09

科室
- - 订阅+
  - 更多科室
工具
服务